EP1379651A2 - Human genes and gene expression products isolated from human prostate - Google Patents

Info

Publication number

EP1379651A2

EP1379651A2 EP01989188A EP01989188A EP1379651A2 EP 1379651 A2 EP1379651 A2 EP 1379651A2 EP 01989188 A EP01989188 A EP 01989188A EP 01989188 A EP01989188 A EP 01989188A EP 1379651 A2 EP1379651 A2 EP 1379651A2

Authority

EP

European Patent Office

Prior art keywords

sep

sequence

seq

polynucleotide

nos

Prior art date

2000-12-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• EPO GPI
• EP Register
• Global Dossier
• Discuss

• 108090000623 proteins and genes Proteins 0.000 title claims abstract description 458
• 230000014509 gene expression Effects 0.000 title claims description 136
• 241000282414 Homo sapiens Species 0.000 title abstract description 61
• 210000002307 prostate Anatomy 0.000 title description 84
• 102000040430 polynucleotide Human genes 0.000 claims abstract description 359
• 108091033319 polynucleotide Proteins 0.000 claims abstract description 359
• 239000002157 polynucleotide Substances 0.000 claims abstract description 359
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 174
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 172
• 229920001184 polypeptide Polymers 0.000 claims abstract description 171
• 125000003729 nucleotide group Chemical group 0.000 claims abstract description 64
• 239000002773 nucleotide Substances 0.000 claims abstract description 59
• 230000000692 anti-sense effect Effects 0.000 claims abstract description 28
• 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 25
• 210000004027 cell Anatomy 0.000 claims description 202
• 238000000034 method Methods 0.000 claims description 128
• 239000002299 complementary DNA Substances 0.000 claims description 101
• 238000001514 detection method Methods 0.000 claims description 43
• 238000003752 polymerase chain reaction Methods 0.000 claims description 27
• 238000012360 testing method Methods 0.000 claims description 24
• 239000013598 vector Substances 0.000 claims description 24
• 238000004519 manufacturing process Methods 0.000 claims description 12
• 230000003321 amplification Effects 0.000 claims description 9
• 238000003199 nucleic acid amplification method Methods 0.000 claims description 9
• 230000000295 complement effect Effects 0.000 claims description 7
• 230000002596 correlated effect Effects 0.000 claims description 6
• 230000002401 inhibitory effect Effects 0.000 claims description 5
• 230000008569 process Effects 0.000 claims description 5
• 210000004962 mammalian cell Anatomy 0.000 claims description 4
• 238000012258 culturing Methods 0.000 claims description 3
• 230000004614 tumor growth Effects 0.000 claims description 3
• 238000004113 cell culture Methods 0.000 claims description 2
• 238000003499 nucleic acid array Methods 0.000 claims description 2
• 102000004169 proteins and genes Human genes 0.000 abstract description 181
• 239000000523 sample Substances 0.000 abstract description 105
• 239000003814 drug Substances 0.000 abstract description 16
• BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 785
• 206010028980 Neoplasm Diseases 0.000 description 214
• 235000018102 proteins Nutrition 0.000 description 167
• 201000011510 cancer Diseases 0.000 description 129
• 239000000047 product Substances 0.000 description 97
• 210000001519 tissue Anatomy 0.000 description 94
• 150000007523 nucleic acids Chemical class 0.000 description 86
• 102000039446 nucleic acids Human genes 0.000 description 80
• 108020004707 nucleic acids Proteins 0.000 description 80
• 230000000875 corresponding effect Effects 0.000 description 77
• 108020004999 messenger RNA Proteins 0.000 description 55
• 235000001014 amino acid Nutrition 0.000 description 52
• 229940024606 amino acid Drugs 0.000 description 48
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 48
• 239000000203 mixture Substances 0.000 description 48
• 108020004414 DNA Proteins 0.000 description 46
• 150000001413 amino acids Chemical class 0.000 description 45
• 230000000694 effects Effects 0.000 description 45
• 201000010099 disease Diseases 0.000 description 39
• 230000027455 binding Effects 0.000 description 37
• 230000001394 metastastic effect Effects 0.000 description 37
• 206010061289 metastatic neoplasm Diseases 0.000 description 37
• 238000003556 assay Methods 0.000 description 33
• 108091034117 Oligonucleotide Proteins 0.000 description 32
• 239000003795 chemical substances by application Substances 0.000 description 30
• 230000006870 function Effects 0.000 description 30
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 29
• 239000012634 fragment Substances 0.000 description 29
• 230000001225 therapeutic effect Effects 0.000 description 28
• 238000009396 hybridization Methods 0.000 description 25
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 24
• 108091035707 Consensus sequence Proteins 0.000 description 23
• 108091028043 Nucleic acid sequence Proteins 0.000 description 21
• 238000011282 treatment Methods 0.000 description 21
• 206010060862 Prostate cancer Diseases 0.000 description 20
• 210000000481 breast Anatomy 0.000 description 20
• 238000003491 array Methods 0.000 description 19
• 102000005962 receptors Human genes 0.000 description 19
• 108020003175 receptors Proteins 0.000 description 19
• 108090000994 Catalytic RNA Proteins 0.000 description 18
• 102000053642 Catalytic RNA Human genes 0.000 description 17
• 210000001072 colon Anatomy 0.000 description 17
• 230000001105 regulatory effect Effects 0.000 description 17
• 108091092562 ribozyme Proteins 0.000 description 17
• 241000894007 species Species 0.000 description 17
• 206010006187 Breast cancer Diseases 0.000 description 16
• 102000004190 Enzymes Human genes 0.000 description 16
• 108090000790 Enzymes Proteins 0.000 description 16
• 238000003745 diagnosis Methods 0.000 description 16
• 210000004379 membrane Anatomy 0.000 description 16
• 239000012528 membrane Substances 0.000 description 16
• 208000026310 Breast neoplasm Diseases 0.000 description 15
• 206010009944 Colon cancer Diseases 0.000 description 14
• 230000004071 biological effect Effects 0.000 description 14
• 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 14
• 238000012384 transportation and delivery Methods 0.000 description 14
• 206010027476 Metastases Diseases 0.000 description 13
• 125000000539 amino acid group Chemical group 0.000 description 13
• 238000004458 analytical method Methods 0.000 description 13
• 230000015572 biosynthetic process Effects 0.000 description 13
• 238000004422 calculation algorithm Methods 0.000 description 13
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 12
• 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 description 12
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 12
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 12
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 12
• 239000000427 antigen Substances 0.000 description 12
• 108091007433 antigens Proteins 0.000 description 12
• 102000036639 antigens Human genes 0.000 description 12
• 208000029742 colonic neoplasm Diseases 0.000 description 12
• 238000002560 therapeutic procedure Methods 0.000 description 12
• 229910052725 zinc Inorganic materials 0.000 description 12
• 239000011701 zinc Substances 0.000 description 12
• 206010073094 Intraductal proliferative breast lesion Diseases 0.000 description 11
• 208000009956 adenocarcinoma Diseases 0.000 description 11
• 210000000349 chromosome Anatomy 0.000 description 11
• 238000011161 development Methods 0.000 description 11
• 201000007273 ductal carcinoma in situ Diseases 0.000 description 11
• 230000012010 growth Effects 0.000 description 11
• 238000002887 multiple sequence alignment Methods 0.000 description 11
• 230000035772 mutation Effects 0.000 description 11
• 239000007787 solid Substances 0.000 description 11
• 208000024891 symptom Diseases 0.000 description 11
• 108020004635 Complementary DNA Proteins 0.000 description 10
• 102000011252 Krueppel-associated box Human genes 0.000 description 10
• 108050001491 Krueppel-associated box Proteins 0.000 description 10
• 102000003792 Metallothionein Human genes 0.000 description 10
• 108090000157 Metallothionein Proteins 0.000 description 10
• 102000001253 Protein Kinase Human genes 0.000 description 10
• 239000005557 antagonist Substances 0.000 description 10
• -1 but not limited to Proteins 0.000 description 10
• 230000003197 catalytic effect Effects 0.000 description 10
• 230000018109 developmental process Effects 0.000 description 10
• 201000005202 lung cancer Diseases 0.000 description 10
• 208000020816 lung neoplasm Diseases 0.000 description 10
• 210000001165 lymph node Anatomy 0.000 description 10
• 108060006633 protein kinase Proteins 0.000 description 10
• 238000012546 transfer Methods 0.000 description 10
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 9
• 108091026890 Coding region Proteins 0.000 description 9
• 108700026244 Open Reading Frames Proteins 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 210000000981 epithelium Anatomy 0.000 description 9
• 230000037433 frameshift Effects 0.000 description 9
• 230000002209 hydrophobic effect Effects 0.000 description 9
• 238000000338 in vitro Methods 0.000 description 9
• 230000003902 lesion Effects 0.000 description 9
• 210000004072 lung Anatomy 0.000 description 9
• 230000001404 mediated effect Effects 0.000 description 9
• 230000009401 metastasis Effects 0.000 description 9
• 238000004393 prognosis Methods 0.000 description 9
• 239000000758 substrate Substances 0.000 description 9
• 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 8
• 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 8
• 239000002253 acid Substances 0.000 description 8
• 238000002405 diagnostic procedure Methods 0.000 description 8
• 230000028993 immune response Effects 0.000 description 8
• 239000003446 ligand Substances 0.000 description 8
• 210000004698 lymphocyte Anatomy 0.000 description 8
• 239000008194 pharmaceutical composition Substances 0.000 description 8
• 238000012216 screening Methods 0.000 description 8
• 238000006467 substitution reaction Methods 0.000 description 8
• 235000000346 sugar Nutrition 0.000 description 8
• 239000003981 vehicle Substances 0.000 description 8
• 230000003612 virological effect Effects 0.000 description 8
• 241000894006 Bacteria Species 0.000 description 7
• 241000196324 Embryophyta Species 0.000 description 7
• 208000007433 Lymphatic Metastasis Diseases 0.000 description 7
• 102000004316 Oxidoreductases Human genes 0.000 description 7
• 108090000854 Oxidoreductases Proteins 0.000 description 7
• 102000015799 Qa-SNARE Proteins Human genes 0.000 description 7
• 108010010469 Qa-SNARE Proteins Proteins 0.000 description 7
• 239000000556 agonist Substances 0.000 description 7
• 238000001574 biopsy Methods 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 239000003153 chemical reaction reagent Substances 0.000 description 7
• 239000013078 crystal Substances 0.000 description 7
• 238000002474 experimental method Methods 0.000 description 7
• 108020001507 fusion proteins Proteins 0.000 description 7
• 102000037865 fusion proteins Human genes 0.000 description 7
• 238000001415 gene therapy Methods 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 238000013507 mapping Methods 0.000 description 7
• 230000000873 masking effect Effects 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• 238000003786 synthesis reaction Methods 0.000 description 7
• 230000014616 translation Effects 0.000 description 7
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• 108091060211 Expressed sequence tag Proteins 0.000 description 6
• 201000006107 Familial adenomatous polyposis Diseases 0.000 description 6
• 239000004471 Glycine Substances 0.000 description 6
• 108010085895 Laminin Proteins 0.000 description 6
• 102000007547 Laminin Human genes 0.000 description 6
• 241001465754 Metazoa Species 0.000 description 6
• 108060008487 Myosin Proteins 0.000 description 6
• 102000003505 Myosin Human genes 0.000 description 6
• 102000000470 PDZ domains Human genes 0.000 description 6
• 108050008994 PDZ domains Proteins 0.000 description 6
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 6
• 239000002246 antineoplastic agent Substances 0.000 description 6
• 230000001580 bacterial effect Effects 0.000 description 6
• 239000012620 biological material Substances 0.000 description 6
• 210000004899 c-terminal region Anatomy 0.000 description 6
• 208000029664 classic familial adenomatous polyposis Diseases 0.000 description 6
• 238000007796 conventional method Methods 0.000 description 6
• 235000018417 cysteine Nutrition 0.000 description 6
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 6
• 239000003937 drug carrier Substances 0.000 description 6
• 230000004927 fusion Effects 0.000 description 6
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 6
• 230000001965 increasing effect Effects 0.000 description 6
• 230000003993 interaction Effects 0.000 description 6
• 238000002372 labelling Methods 0.000 description 6
• 230000002438 mitochondrial effect Effects 0.000 description 6
• 102000005309 phosducin Human genes 0.000 description 6
• 108010031256 phosducin Proteins 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 238000011160 research Methods 0.000 description 6
• 238000003860 storage Methods 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• 238000013519 translation Methods 0.000 description 6
• 108010049777 Ankyrins Proteins 0.000 description 5
• 102000008102 Ankyrins Human genes 0.000 description 5
• 108020005544 Antisense RNA Proteins 0.000 description 5
• 108010078791 Carrier Proteins Proteins 0.000 description 5
• 102000030782 GTP binding Human genes 0.000 description 5
• 108091000058 GTP-Binding Proteins 0.000 description 5
• 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 5
• 101000662049 Homo sapiens Polyubiquitin-C Proteins 0.000 description 5
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 5
• 206010027459 Metastases to lymph nodes Diseases 0.000 description 5
• 102100040216 Mitochondrial uncoupling protein 3 Human genes 0.000 description 5
• 101710112412 Mitochondrial uncoupling protein 3 Proteins 0.000 description 5
• 102100037935 Polyubiquitin-C Human genes 0.000 description 5
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 5
• 102000004142 Trypsin Human genes 0.000 description 5
• 108090000631 Trypsin Proteins 0.000 description 5
• 230000002159 abnormal effect Effects 0.000 description 5
• 150000007513 acids Chemical class 0.000 description 5
• 230000004075 alteration Effects 0.000 description 5
• 239000012472 biological sample Substances 0.000 description 5
• 230000037396 body weight Effects 0.000 description 5
• 239000003184 complementary RNA Substances 0.000 description 5
• 238000013500 data storage Methods 0.000 description 5
• 230000007423 decrease Effects 0.000 description 5
• 238000013461 design Methods 0.000 description 5
• 230000004069 differentiation Effects 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 238000005516 engineering process Methods 0.000 description 5
• 239000007850 fluorescent dye Substances 0.000 description 5
• 238000000370 laser capture micro-dissection Methods 0.000 description 5
• 210000002751 lymph Anatomy 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 5
• 229910052757 nitrogen Inorganic materials 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 239000002245 particle Substances 0.000 description 5
• 230000026731 phosphorylation Effects 0.000 description 5
• 238000006366 phosphorylation reaction Methods 0.000 description 5
• 230000005855 radiation Effects 0.000 description 5
• 238000007423 screening assay Methods 0.000 description 5
• 239000007858 starting material Substances 0.000 description 5
• 229940124597 therapeutic agent Drugs 0.000 description 5
• 229960005486 vaccine Drugs 0.000 description 5
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
• 241000283690 Bos taurus Species 0.000 description 4
• 102000000584 Calmodulin Human genes 0.000 description 4
• 108010041952 Calmodulin Proteins 0.000 description 4
• 102000014914 Carrier Proteins Human genes 0.000 description 4
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 4
• 102000018832 Cytochromes Human genes 0.000 description 4
• 108010052832 Cytochromes Proteins 0.000 description 4
• 102000010719 DNA-(Apurinic or Apyrimidinic Site) Lyase Human genes 0.000 description 4
• 108010063362 DNA-(Apurinic or Apyrimidinic Site) Lyase Proteins 0.000 description 4
• 108700024394 Exon Proteins 0.000 description 4
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
• 108091092195 Intron Proteins 0.000 description 4
• 102000003960 Ligases Human genes 0.000 description 4
• 108090000364 Ligases Proteins 0.000 description 4
• 102000018697 Membrane Proteins Human genes 0.000 description 4
• 108010052285 Membrane Proteins Proteins 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• 241000699670 Mus sp. Species 0.000 description 4
• 238000000636 Northern blotting Methods 0.000 description 4
• 108010076504 Protein Sorting Signals Proteins 0.000 description 4
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 4
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• 108091023040 Transcription factor Proteins 0.000 description 4
• 102000040945 Transcription factor Human genes 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 230000033228 biological regulation Effects 0.000 description 4
• 210000004369 blood Anatomy 0.000 description 4
• 239000008280 blood Substances 0.000 description 4
• 239000002775 capsule Substances 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 238000010276 construction Methods 0.000 description 4
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
• 230000001086 cytosolic effect Effects 0.000 description 4
• 230000003247 decreasing effect Effects 0.000 description 4
• 238000012217 deletion Methods 0.000 description 4
• 230000037430 deletion Effects 0.000 description 4
• 230000003511 endothelial effect Effects 0.000 description 4
• 239000000284 extract Substances 0.000 description 4
• 210000003754 fetus Anatomy 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• 238000001476 gene delivery Methods 0.000 description 4
• 230000002068 genetic effect Effects 0.000 description 4
• 230000013595 glycosylation Effects 0.000 description 4
• 238000006206 glycosylation reaction Methods 0.000 description 4
• 210000003128 head Anatomy 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 239000002502 liposome Substances 0.000 description 4
• 210000004185 liver Anatomy 0.000 description 4
• 230000003211 malignant effect Effects 0.000 description 4
• 238000007726 management method Methods 0.000 description 4
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
• 238000002493 microarray Methods 0.000 description 4
• 238000010369 molecular cloning Methods 0.000 description 4
• 210000000056 organ Anatomy 0.000 description 4
• 150000008300 phosphoramidites Chemical group 0.000 description 4
• 239000013612 plasmid Substances 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 102000054765 polymorphisms of proteins Human genes 0.000 description 4
• 208000023958 prostate neoplasm Diseases 0.000 description 4
• 230000002285 radioactive effect Effects 0.000 description 4
• NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 4
• 108091008146 restriction endonucleases Proteins 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 150000003839 salts Chemical class 0.000 description 4
• 238000010845 search algorithm Methods 0.000 description 4
• 238000002864 sequence alignment Methods 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 238000001890 transfection Methods 0.000 description 4
• 239000012588 trypsin Substances 0.000 description 4
• 210000004881 tumor cell Anatomy 0.000 description 4
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
• 102100035322 60S ribosomal protein L24 Human genes 0.000 description 3
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
• 108020004705 Codon Proteins 0.000 description 3
• 229930105110 Cyclosporin A Natural products 0.000 description 3
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 3
• 108010036949 Cyclosporine Proteins 0.000 description 3
• 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 3
• 108090000365 Cytochrome-c oxidases Proteins 0.000 description 3
• 101100125027 Dictyostelium discoideum mhsp70 gene Proteins 0.000 description 3
• 108010042407 Endonucleases Proteins 0.000 description 3
• 101800003838 Epidermal growth factor Proteins 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• 241000588724 Escherichia coli Species 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 241000206602 Eukaryota Species 0.000 description 3
• 101150031823 HSP70 gene Proteins 0.000 description 3
• 101000753286 Homo sapiens Transcription intermediary factor 1-beta Proteins 0.000 description 3
• 206010021929 Infertility male Diseases 0.000 description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
• 239000004472 Lysine Substances 0.000 description 3
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 3
• 208000007466 Male Infertility Diseases 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 102000005604 Myosin Heavy Chains Human genes 0.000 description 3
• 108010084498 Myosin Heavy Chains Proteins 0.000 description 3
• 108010020943 Nitrogenase Proteins 0.000 description 3
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
• 108700020796 Oncogene Proteins 0.000 description 3
• 102000043276 Oncogene Human genes 0.000 description 3
• 241001631646 Papillomaviridae Species 0.000 description 3
• 102100037026 Peptidyl-prolyl cis-trans isomerase FKBP5 Human genes 0.000 description 3
• FKUYMLZIRPABFK-UHFFFAOYSA-N Plastoquinone 9 Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=CC(=O)C(C)=C(C)C1=O FKUYMLZIRPABFK-UHFFFAOYSA-N 0.000 description 3
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 3
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 3
• 102100038358 Prostate-specific antigen Human genes 0.000 description 3
• 239000013614 RNA sample Substances 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 241000283984 Rodentia Species 0.000 description 3
• 238000012300 Sequence Analysis Methods 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 238000002105 Southern blotting Methods 0.000 description 3
• 108091027544 Subgenomic mRNA Proteins 0.000 description 3
• 102000013265 Syntaxin 1 Human genes 0.000 description 3
• 108010090618 Syntaxin 1 Proteins 0.000 description 3
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• 102100022012 Transcription intermediary factor 1-beta Human genes 0.000 description 3
• 102000044159 Ubiquitin Human genes 0.000 description 3
• 108090000848 Ubiquitin Proteins 0.000 description 3
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
• 235000004279 alanine Nutrition 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 210000000612 antigen-presenting cell Anatomy 0.000 description 3
• 239000000074 antisense oligonucleotide Substances 0.000 description 3
• 238000012230 antisense oligonucleotides Methods 0.000 description 3
• CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000004663 cell proliferation Effects 0.000 description 3
• 229960001265 ciclosporin Drugs 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 238000004590 computer program Methods 0.000 description 3
• 239000013068 control sample Substances 0.000 description 3
• 229910052802 copper Inorganic materials 0.000 description 3
• 239000010949 copper Substances 0.000 description 3
• 101150052825 dnaK gene Proteins 0.000 description 3
• 210000002889 endothelial cell Anatomy 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 229940116977 epidermal growth factor Drugs 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 239000000499 gel Substances 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 238000003384 imaging method Methods 0.000 description 3
• 238000007901 in situ hybridization Methods 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 125000005647 linker group Chemical group 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 229910021645 metal ion Inorganic materials 0.000 description 3
• 239000013642 negative control Substances 0.000 description 3
• 229940060155 neuac Drugs 0.000 description 3
• 230000000683 nonmetastatic effect Effects 0.000 description 3
• 239000002853 nucleic acid probe Substances 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
• DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 210000003705 ribosome Anatomy 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 230000035945 sensitivity Effects 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 3
• 229940035936 ubiquinone Drugs 0.000 description 3
• 210000002700 urine Anatomy 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 2
• BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
• 102100021546 60S ribosomal protein L10 Human genes 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 108700028369 Alleles Proteins 0.000 description 2
• 108010031677 Anaphase-Promoting Complex-Cyclosome Proteins 0.000 description 2
• 102000005446 Anaphase-Promoting Complex-Cyclosome Human genes 0.000 description 2
• 108090001008 Avidin Proteins 0.000 description 2
• 101000623895 Bos taurus Mucin-15 Proteins 0.000 description 2
• 102000002110 C2 domains Human genes 0.000 description 2
• 108050009459 C2 domains Proteins 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 201000009030 Carcinoma Diseases 0.000 description 2
• 108091006146 Channels Proteins 0.000 description 2
• 101710163595 Chaperone protein DnaK Proteins 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• 241001227713 Chiron Species 0.000 description 2
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
• ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
• 108010068682 Cyclophilins Proteins 0.000 description 2
• 102000001493 Cyclophilins Human genes 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 102000012410 DNA Ligases Human genes 0.000 description 2
• 108010061982 DNA Ligases Proteins 0.000 description 2
• 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 2
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 2
• 239000003298 DNA probe Substances 0.000 description 2
• 206010058314 Dysplasia Diseases 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 102100039328 Endoplasmin Human genes 0.000 description 2
• 241000282324 Felis Species 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 108091006027 G proteins Proteins 0.000 description 2
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
• 102000009465 Growth Factor Receptors Human genes 0.000 description 2
• 108010009202 Growth Factor Receptors Proteins 0.000 description 2
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 2
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 2
• 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 2
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
• 208000008051 Hereditary Nonpolyposis Colorectal Neoplasms Diseases 0.000 description 2
• 208000017095 Hereditary nonpolyposis colon cancer Diseases 0.000 description 2
• 108010034791 Heterochromatin Proteins 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 101001108634 Homo sapiens 60S ribosomal protein L10 Proteins 0.000 description 2
• 101000725401 Homo sapiens Cytochrome c oxidase subunit 2 Proteins 0.000 description 2
• 101000878213 Homo sapiens Inactive peptidyl-prolyl cis-trans isomerase FKBP6 Proteins 0.000 description 2
• 101001006782 Homo sapiens Kinesin-associated protein 3 Proteins 0.000 description 2
• 101000605127 Homo sapiens Prostaglandin G/H synthase 2 Proteins 0.000 description 2
• 101001092156 Homo sapiens Regulator of G-protein signaling 12 Proteins 0.000 description 2
• 102100036984 Inactive peptidyl-prolyl cis-trans isomerase FKBP6 Human genes 0.000 description 2
• 108060004056 Integrin alpha Chain Proteins 0.000 description 2
• 108090000862 Ion Channels Proteins 0.000 description 2
• 102000004310 Ion Channels Human genes 0.000 description 2
• 108010044467 Isoenzymes Proteins 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• 101710126995 Late expression factor 2 Proteins 0.000 description 2
• 241000701409 Lymantria dispar multiple nucleopolyhedrovirus Species 0.000 description 2
• 108091027974 Mature messenger RNA Proteins 0.000 description 2
• 102000007474 Multiprotein Complexes Human genes 0.000 description 2
• 108010085220 Multiprotein Complexes Proteins 0.000 description 2
• 108010081778 N-acylneuraminate cytidylyltransferase Proteins 0.000 description 2
• 108090000974 NADH dehydrogenase (quinone) Proteins 0.000 description 2
• 108091061960 Naked DNA Proteins 0.000 description 2
• 241000244206 Nematoda Species 0.000 description 2
• 102000048850 Neoplasm Genes Human genes 0.000 description 2
• 108700019961 Neoplasm Genes Proteins 0.000 description 2
• 102100023206 Neuromodulin Human genes 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 108091059562 NifH/frxC family Proteins 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
• 108010038807 Oligopeptides Proteins 0.000 description 2
• 102000015636 Oligopeptides Human genes 0.000 description 2
• 241000052303 Orgyia pseudotsugata multiple nucleopolyhedrovirus Species 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 238000012408 PCR amplification Methods 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 108010067902 Peptide Library Proteins 0.000 description 2
• 208000002151 Pleural effusion Diseases 0.000 description 2
• 229920000954 Polyglycolide Polymers 0.000 description 2
• 208000037062 Polyps Diseases 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108090000315 Protein Kinase C Proteins 0.000 description 2
• 102000003923 Protein Kinase C Human genes 0.000 description 2
• 102100034419 Ras GTPase-activating-like protein IQGAP1 Human genes 0.000 description 2
• 102100035772 Regulator of G-protein signaling 12 Human genes 0.000 description 2
• 102000006382 Ribonucleases Human genes 0.000 description 2
• 108010083644 Ribonucleases Proteins 0.000 description 2
• 102000004389 Ribonucleoproteins Human genes 0.000 description 2
• 108010081734 Ribonucleoproteins Proteins 0.000 description 2
• 102000012479 Serine Proteases Human genes 0.000 description 2
• 108010022999 Serine Proteases Proteins 0.000 description 2
• 108010089417 Sex Hormone-Binding Globulin Proteins 0.000 description 2
• 102100030758 Sex hormone-binding globulin Human genes 0.000 description 2
• 108091027568 Single-stranded nucleotide Proteins 0.000 description 2
• 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 2
• 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• 102000006612 Transducin Human genes 0.000 description 2
• 108010087042 Transducin Proteins 0.000 description 2
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 2
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 2
• 101710185494 Zinc finger protein Proteins 0.000 description 2
• 102100023597 Zinc finger protein 816 Human genes 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 229910021529 ammonia Inorganic materials 0.000 description 2
• 239000012491 analyte Substances 0.000 description 2
• 238000004873 anchoring Methods 0.000 description 2
• 230000001093 anti-cancer Effects 0.000 description 2
• 229940041181 antineoplastic drug Drugs 0.000 description 2
• 230000006907 apoptotic process Effects 0.000 description 2
• 210000001367 artery Anatomy 0.000 description 2
• 125000003118 aryl group Chemical group 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000006399 behavior Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 239000013060 biological fluid Substances 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• 239000010839 body fluid Substances 0.000 description 2
• 210000000988 bone and bone Anatomy 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 229910052793 cadmium Inorganic materials 0.000 description 2
• BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 150000001768 cations Chemical class 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 235000017471 coenzyme Q10 Nutrition 0.000 description 2
• ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
• 230000005757 colony formation Effects 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 108010023472 cytochrome C oxidase subunit II Proteins 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 238000002716 delivery method Methods 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 239000001177 diphosphate Substances 0.000 description 2
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
• 235000011180 diphosphates Nutrition 0.000 description 2
• 238000007877 drug screening Methods 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 239000013604 expression vector Substances 0.000 description 2
• 210000003414 extremity Anatomy 0.000 description 2
• 208000020603 familial colorectal cancer Diseases 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 150000004665 fatty acids Chemical class 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 238000002825 functional assay Methods 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
• 239000000710 homodimer Substances 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000003463 hyperproliferative effect Effects 0.000 description 2
• 230000000984 immunochemical effect Effects 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 102000017777 integrin alpha chain Human genes 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 230000005865 ionizing radiation Effects 0.000 description 2
• 102000034069 iron-sulfur cluster binding proteins Human genes 0.000 description 2
• 108091000402 iron-sulfur cluster binding proteins Proteins 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 201000005296 lung carcinoma Diseases 0.000 description 2
• 210000005265 lung cell Anatomy 0.000 description 2
• 210000004924 lung microvascular endothelial cell Anatomy 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 230000027939 micturition Effects 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 238000003032 molecular docking Methods 0.000 description 2
• 238000000329 molecular dynamics simulation Methods 0.000 description 2
• 201000010879 mucinous adenocarcinoma Diseases 0.000 description 2
• 229930014626 natural product Natural products 0.000 description 2
• 230000009826 neoplastic cell growth Effects 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 108010015857 nitrogenase reductase Proteins 0.000 description 2
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
• 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 2
• 238000011275 oncology therapy Methods 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 150000002894 organic compounds Chemical class 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
• 229910052698 phosphorus Inorganic materials 0.000 description 2
• 210000004560 pineal gland Anatomy 0.000 description 2
• 210000002381 plasma Anatomy 0.000 description 2
• 229920000747 poly(lactic acid) Polymers 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 210000005267 prostate cell Anatomy 0.000 description 2
• 230000012846 protein folding Effects 0.000 description 2
• 230000004850 protein–protein interaction Effects 0.000 description 2
• 210000001938 protoplast Anatomy 0.000 description 2
• 238000001959 radiotherapy Methods 0.000 description 2
• 230000022983 regulation of cell cycle Effects 0.000 description 2
• 230000003252 repetitive effect Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
• 108010025463 ribosomal protein L24 Proteins 0.000 description 2
• 238000003196 serial analysis of gene expression Methods 0.000 description 2
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 208000000649 small cell carcinoma Diseases 0.000 description 2
• 239000001509 sodium citrate Substances 0.000 description 2
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
• 206010041823 squamous cell carcinoma Diseases 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
• 230000000699 topical effect Effects 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000001131 transforming effect Effects 0.000 description 2
• 102000027257 transmembrane receptors Human genes 0.000 description 2
• 108091008578 transmembrane receptors Proteins 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
• 229940040064 ubiquinol Drugs 0.000 description 2
• QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 230000028973 vesicle-mediated transport Effects 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• YQCXUOPQUQUHAN-RLPXVTJZSA-L zinc (2R)-2-amino-3-hydroxy-3-oxopropane-1-thiolate (2S)-2-amino-3-imidazol-1-id-4-ylpropanoic acid hydron Chemical group [H+].[H+].[Zn++].N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](Cc1c[n-]cn1)C(O)=O YQCXUOPQUQUHAN-RLPXVTJZSA-L 0.000 description 2
• OFMQLVRLOGHAJI-FGHAYEPSSA-N (4r,7s,10s,13r,16s,19r)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-10-[3-(diaminomethylideneamino)propyl]-7-[(1r)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18 Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N[C@@H](C(SSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=CC=CC=1)(C)C)C(=O)N[C@@H]([C@H](O)C)C(N)=O)[C@@H](C)O)C1=CC=C(O)C=C1 OFMQLVRLOGHAJI-FGHAYEPSSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
• ARVQIYGIIOWVCP-UHFFFAOYSA-N 2-cyanoethyl dihydrogen phosphite Chemical compound OP(O)OCCC#N ARVQIYGIIOWVCP-UHFFFAOYSA-N 0.000 description 1
• 108030002525 3-deoxy-manno-octulosonate cytidylyltransferases Proteins 0.000 description 1
• KYQCXUMVJGMDNG-UHFFFAOYSA-N 4,5,6,7,8-pentahydroxy-2-oxooctanoic acid Chemical compound OCC(O)C(O)C(O)C(O)CC(=O)C(O)=O KYQCXUMVJGMDNG-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• 101150079978 AGRN gene Proteins 0.000 description 1
• 108091006112 ATPases Proteins 0.000 description 1
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 102100033647 Activity-regulated cytoskeleton-associated protein Human genes 0.000 description 1
• 102000016515 Acylneuraminate cytidylyltransferases Human genes 0.000 description 1
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
• 102100040026 Agrin Human genes 0.000 description 1
• 108700019743 Agrin Proteins 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• 108091023043 Alu Element Proteins 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 101710091620 Apoptosis-stimulating of p53 protein 2 Proteins 0.000 description 1
• 108091023037 Aptamer Proteins 0.000 description 1
• 241000219195 Arabidopsis thaliana Species 0.000 description 1
• 101100004644 Arabidopsis thaliana BAT1 gene Proteins 0.000 description 1
• 241000945470 Arcturus Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 240000003291 Armoracia rusticana Species 0.000 description 1
• 235000011330 Armoracia rusticana Nutrition 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
• 108010006654 Bleomycin Proteins 0.000 description 1
• 210000003771 C cell Anatomy 0.000 description 1
• 102100036841 C-C motif chemokine 1 Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100025905 C-Jun-amino-terminal kinase-interacting protein 4 Human genes 0.000 description 1
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• YWWJKULNWGRYAS-UOVSKDHASA-N CMP-3-deoxy-beta-D-manno-octulosonic acid Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)O[C@@]2(O[C@@H]([C@H](O)[C@H](O)C2)[C@H](O)CO)C(O)=O)O1 YWWJKULNWGRYAS-UOVSKDHASA-N 0.000 description 1
• TXCIAUNLDRJGJZ-BILDWYJOSA-N CMP-N-acetyl-beta-neuraminic acid Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@]1(C(O)=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(N=C(N)C=C2)=O)O1 TXCIAUNLDRJGJZ-BILDWYJOSA-N 0.000 description 1
• 101100014810 Caenorhabditis elegans glh-1 gene Proteins 0.000 description 1
• 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 description 1
• 101100252357 Caenorhabditis elegans rnp-1 gene Proteins 0.000 description 1
• 102100036339 Calmodulin-like protein 3 Human genes 0.000 description 1
• 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 102000005483 Cell Cycle Proteins Human genes 0.000 description 1
• 108010031896 Cell Cycle Proteins Proteins 0.000 description 1
• 108050001186 Chaperonin Cpn60 Proteins 0.000 description 1
• 102000052603 Chaperonins Human genes 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 102000003813 Cis-trans-isomerases Human genes 0.000 description 1
• 108090000175 Cis-trans-isomerases Proteins 0.000 description 1
• 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
• 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 206010055114 Colon cancer metastatic Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 101001120236 Crotalus durissus cumanensis Basic phospholipase A2 10 Proteins 0.000 description 1
• 241000238424 Crustacea Species 0.000 description 1
• 241000192700 Cyanobacteria Species 0.000 description 1
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
• 108010072220 Cyclophilin A Proteins 0.000 description 1
• 108020003215 DNA Probes Proteins 0.000 description 1
• 239000012623 DNA damaging agent Substances 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 231100001074 DNA strand break Toxicity 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 101100016370 Danio rerio hsp90a.1 gene Proteins 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 101100216227 Dictyostelium discoideum anapc3 gene Proteins 0.000 description 1
• 101100495257 Dictyostelium discoideum anapc8 gene Proteins 0.000 description 1
• 101100285708 Dictyostelium discoideum hspD gene Proteins 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 108010071079 Dinitrogenase Reductase Proteins 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 101500025735 Drosophila melanogaster CAP-3 Proteins 0.000 description 1
• 208000006402 Ductal Carcinoma Diseases 0.000 description 1
• 108010093446 Dystrophin-Associated Proteins Proteins 0.000 description 1
• 102000002578 Dystrophin-Associated Proteins Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 102000018386 EGF Family of Proteins Human genes 0.000 description 1
• 108010066486 EGF Family of Proteins Proteins 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 230000012215 ER to Golgi vesicle-mediated transport Effects 0.000 description 1
• 241000257465 Echinoidea Species 0.000 description 1
• 108010089760 Electron Transport Complex I Proteins 0.000 description 1
• 102000008013 Electron Transport Complex I Human genes 0.000 description 1
• 102000015782 Electron Transport Complex III Human genes 0.000 description 1
• 108010024882 Electron Transport Complex III Proteins 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 102000004533 Endonucleases Human genes 0.000 description 1
• 102100030013 Endoribonuclease Human genes 0.000 description 1
• 108010093099 Endoribonucleases Proteins 0.000 description 1
• 244000148064 Enicostema verticillatum Species 0.000 description 1
• 206010066919 Epidemic polyarthritis Diseases 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 101100266802 Escherichia coli (strain K12) ychF gene Proteins 0.000 description 1
• 108050001049 Extracellular proteins Proteins 0.000 description 1
• 208000014061 Extranodal Extension Diseases 0.000 description 1
• 101710103508 FK506-binding protein Proteins 0.000 description 1
• 101710104425 FK506-binding protein 2 Proteins 0.000 description 1
• 101710104423 FK506-binding protein 3 Proteins 0.000 description 1
• 101710104333 FK506-binding protein 4 Proteins 0.000 description 1
• 101710104342 FK506-binding protein 5 Proteins 0.000 description 1
• 101710149710 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• 101710121306 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• 101710180800 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA Proteins 0.000 description 1
• 108010074122 Ferredoxins Proteins 0.000 description 1
• 108010003471 Fetal Proteins Proteins 0.000 description 1
• 102000004641 Fetal Proteins Human genes 0.000 description 1
• 108010057366 Flavodoxin Proteins 0.000 description 1
• 102000034286 G proteins Human genes 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 101100226596 Gallus gallus FABP gene Proteins 0.000 description 1
• 208000000321 Gardner Syndrome Diseases 0.000 description 1
• 206010056740 Genital discharge Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102000042092 Glucose transporter family Human genes 0.000 description 1
• 108091052347 Glucose transporter family Proteins 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
• 101000636168 Grapevine leafroll-associated virus 3 (isolate United States/NY1) Movement protein p5 Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 108020004202 Guanylate Kinase Proteins 0.000 description 1
• 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
• 102100032510 Heat shock protein HSP 90-beta Human genes 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 108091027305 Heteroduplex Proteins 0.000 description 1
• 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
• 102100035042 Histone-lysine N-methyltransferase EHMT2 Human genes 0.000 description 1
• 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 description 1
• 101001076862 Homo sapiens C-Jun-amino-terminal kinase-interacting protein 4 Proteins 0.000 description 1
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 1
• 101000714692 Homo sapiens Calmodulin-like protein 3 Proteins 0.000 description 1
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
• 101001016856 Homo sapiens Heat shock protein HSP 90-beta Proteins 0.000 description 1
• 101000877312 Homo sapiens Histone-lysine N-methyltransferase EHMT2 Proteins 0.000 description 1
• 101000979249 Homo sapiens Neuromodulin Proteins 0.000 description 1
• 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
• 101000613251 Homo sapiens Tumor susceptibility gene 101 protein Proteins 0.000 description 1
• 101000964562 Homo sapiens Zinc finger FYVE domain-containing protein 9 Proteins 0.000 description 1
• 101000730644 Homo sapiens Zinc finger protein PLAGL2 Proteins 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
• 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 description 1
• 108010050332 IQ motif containing GTPase activating protein 1 Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 102000000521 Immunophilins Human genes 0.000 description 1
• 108010016648 Immunophilins Proteins 0.000 description 1
• 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 description 1
• 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• CIPFCGZLFXVXBG-FTSGZOCFSA-N Inositol 1,3,4,5-tetraphosphate Chemical compound O[C@H]1C(OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)C(OP(O)(O)=O)[C@H]1OP(O)(O)=O CIPFCGZLFXVXBG-FTSGZOCFSA-N 0.000 description 1
• 102100023915 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 1
• 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 description 1
• 102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 1
• 108091029795 Intergenic region Proteins 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 208000032177 Intestinal Polyps Diseases 0.000 description 1
• 241000588747 Klebsiella pneumoniae Species 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 235000019687 Lamb Nutrition 0.000 description 1
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
• 101000988090 Leishmania donovani Heat shock protein 83 Proteins 0.000 description 1
• 241000270322 Lepidosauria Species 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 208000000265 Lobular Carcinoma Diseases 0.000 description 1
• 206010073099 Lobular breast carcinoma in situ Diseases 0.000 description 1
• 101710104030 Long-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 108091077533 MAGUK family Proteins 0.000 description 1
• 102000042189 MAGUK family Human genes 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
• 102100025169 Max-binding protein MNT Human genes 0.000 description 1
• 208000007054 Medullary Carcinoma Diseases 0.000 description 1
• 241000237852 Mollusca Species 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 108010038629 Molybdoferredoxin Proteins 0.000 description 1
• 108700005084 Multigene Family Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101000805948 Mus musculus Harmonin Proteins 0.000 description 1
• 102100038893 Myelin transcription factor 1 Human genes 0.000 description 1
• 101710104371 Myelin transcription factor 1 Proteins 0.000 description 1
• 102000016349 Myosin Light Chains Human genes 0.000 description 1
• 108010067385 Myosin Light Chains Proteins 0.000 description 1
• 241000863422 Myxococcus xanthus Species 0.000 description 1
• 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
• 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
• SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
• SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 1
• 108010002998 NADPH Oxidases Proteins 0.000 description 1
• 102000004722 NADPH Oxidases Human genes 0.000 description 1
• 101710204212 Neocarzinostatin Proteins 0.000 description 1
• 206010061309 Neoplasm progression Diseases 0.000 description 1
• 102000001775 Neurogranin Human genes 0.000 description 1
• 108010015301 Neurogranin Proteins 0.000 description 1
• 101710144282 Neuromodulin Proteins 0.000 description 1
• 101100290388 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) rnp-2 gene Proteins 0.000 description 1
• 102000006538 Nitric Oxide Synthase Type I Human genes 0.000 description 1
• 108010008858 Nitric Oxide Synthase Type I Proteins 0.000 description 1
• 108010070047 Notch Receptors Proteins 0.000 description 1
• 102000005650 Notch Receptors Human genes 0.000 description 1
• 102000043141 Nuclear RNA Human genes 0.000 description 1
• 108020003217 Nuclear RNA Proteins 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 101710114693 Outer membrane protein MIP Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000025618 Paget disease of nipple Diseases 0.000 description 1
• 208000024024 Paget disease of the nipple Diseases 0.000 description 1
• 241000237509 Patinopecten sp. Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 229940122985 Peptide agonist Drugs 0.000 description 1
• 229940083963 Peptide antagonist Drugs 0.000 description 1
• 108010037490 Peptidyl-Prolyl Cis-Trans Isomerase NIMA-Interacting 4 Proteins 0.000 description 1
• 101710116692 Peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
• 102100037827 Peptidyl-prolyl cis-trans isomerase D Human genes 0.000 description 1
• 101710111213 Peptidyl-prolyl cis-trans isomerase D Proteins 0.000 description 1
• 101710111764 Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 description 1
• 101710111749 Peptidyl-prolyl cis-trans isomerase FKBP11 Proteins 0.000 description 1
• 101710111747 Peptidyl-prolyl cis-trans isomerase FKBP12 Proteins 0.000 description 1
• 101710111757 Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 description 1
• 101710111682 Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 description 1
• 101710111689 Peptidyl-prolyl cis-trans isomerase FKBP1B Proteins 0.000 description 1
• 101710147154 Peptidyl-prolyl cis-trans isomerase FKBP2 Proteins 0.000 description 1
• 101710147149 Peptidyl-prolyl cis-trans isomerase FKBP3 Proteins 0.000 description 1
• 101710147152 Peptidyl-prolyl cis-trans isomerase FKBP4 Proteins 0.000 description 1
• 101710147150 Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 description 1
• 101710147138 Peptidyl-prolyl cis-trans isomerase FKBP7 Proteins 0.000 description 1
• 101710147137 Peptidyl-prolyl cis-trans isomerase FKBP8 Proteins 0.000 description 1
• 101710147136 Peptidyl-prolyl cis-trans isomerase FKBP9 Proteins 0.000 description 1
• 101710174853 Peptidyl-prolyl cis-trans isomerase Mip Proteins 0.000 description 1
• 101710200991 Peptidyl-prolyl cis-trans isomerase, rhodopsin-specific isozyme Proteins 0.000 description 1
• 101710092145 Peptidyl-prolyl cis-trans isomerase-like 1 Proteins 0.000 description 1
• 101710092146 Peptidyl-prolyl cis-trans isomerase-like 2 Proteins 0.000 description 1
• 101710092148 Peptidyl-prolyl cis-trans isomerase-like 3 Proteins 0.000 description 1
• 101710092149 Peptidyl-prolyl cis-trans isomerase-like 4 Proteins 0.000 description 1
• 108010020062 Peptidylprolyl Isomerase Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102000007982 Phosphoproteins Human genes 0.000 description 1
• 108010089430 Phosphoproteins Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 208000002163 Phyllodes Tumor Diseases 0.000 description 1
• 206010071776 Phyllodes tumour Diseases 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 102100030304 Platelet factor 4 Human genes 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 229920001710 Polyorthoester Polymers 0.000 description 1
• 101710113444 Probable parvulin-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• 101710090737 Probable peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010066124 Protein S Proteins 0.000 description 1
• 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
• 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
• 229930185560 Pseudouridine Natural products 0.000 description 1
• PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 1
• 101710133309 Putative peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 108091034057 RNA (poly(A)) Proteins 0.000 description 1
• 102000009572 RNA Polymerase II Human genes 0.000 description 1
• 108010009460 RNA Polymerase II Proteins 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 101710145390 Ras GTPase-activating-like protein IQGAP1 Proteins 0.000 description 1
• 101100269971 Rattus norvegicus Apbb1 gene Proteins 0.000 description 1
• 108091007187 Reductases Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 108010000605 Ribosomal Proteins Proteins 0.000 description 1
• 102000002278 Ribosomal Proteins Human genes 0.000 description 1
• 241000710942 Ross River virus Species 0.000 description 1
• 102100022335 SHC-transforming protein 2 Human genes 0.000 description 1
• 101710135817 SHC-transforming protein 2 Proteins 0.000 description 1
• 108091006296 SLC2A1 Proteins 0.000 description 1
• 108091006304 SLC2A7 Proteins 0.000 description 1
• 101100167281 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CIN4 gene Proteins 0.000 description 1
• 101100016060 Schizosaccharomyces pombe (strain 972 / ATCC 24843) gtp1 gene Proteins 0.000 description 1
• 101100512548 Schizosaccharomyces pombe (strain 972 / ATCC 24843) mcm10 gene Proteins 0.000 description 1
• 101100071627 Schizosaccharomyces pombe (strain 972 / ATCC 24843) swo1 gene Proteins 0.000 description 1
• 108010058778 Schizosaccharomyces pombe Proteins Proteins 0.000 description 1
• 241000710961 Semliki Forest virus Species 0.000 description 1
• 108091081021 Sense strand Proteins 0.000 description 1
• 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
• 101710124237 Short-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
• 102000003838 Sialyltransferases Human genes 0.000 description 1
• 108090000141 Sialyltransferases Proteins 0.000 description 1
• 244000044822 Simmondsia californica Species 0.000 description 1
• 235000004433 Simmondsia californica Nutrition 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 102000039471 Small Nuclear RNA Human genes 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• 102100023536 Solute carrier family 2, facilitated glucose transporter member 1 Human genes 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 241000251131 Sphyrna Species 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 206010042658 Sweat gland tumour Diseases 0.000 description 1
• 102100035936 Syntaxin-2 Human genes 0.000 description 1
• 108700038219 Syntaxin-2 Proteins 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 101710137500 T7 RNA polymerase Proteins 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• PEEAINPHPNDNGE-JQWIXIFHSA-N Trp-Asp Chemical group C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 PEEAINPHPNDNGE-JQWIXIFHSA-N 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102000004243 Tubulin Human genes 0.000 description 1
• 108090000704 Tubulin Proteins 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100040879 Tumor susceptibility gene 101 protein Human genes 0.000 description 1
• 102000018686 U4-U6 Small Nuclear Ribonucleoprotein Human genes 0.000 description 1
• 108010091808 U4-U6 Small Nuclear Ribonucleoprotein Proteins 0.000 description 1
• 102000006837 U5 Small Nuclear Ribonucleoprotein Human genes 0.000 description 1
• 108010086857 U5 Small Nuclear Ribonucleoprotein Proteins 0.000 description 1
• 102000018478 Ubiquitin-Activating Enzymes Human genes 0.000 description 1
• 108010091546 Ubiquitin-Activating Enzymes Proteins 0.000 description 1
• 108060008747 Ubiquitin-Conjugating Enzyme Proteins 0.000 description 1
• 102000003431 Ubiquitin-Conjugating Enzyme Human genes 0.000 description 1
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 102100028885 Vitamin K-dependent protein S Human genes 0.000 description 1
• 241000269370 Xenopus <genus> Species 0.000 description 1
• 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
• 102100040801 Zinc finger FYVE domain-containing protein 9 Human genes 0.000 description 1
• 102100032571 Zinc finger protein PLAGL2 Human genes 0.000 description 1
• 230000001594 aberrant effect Effects 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 201000008395 adenosquamous carcinoma Diseases 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 208000018234 adnexal spiradenoma/cylindroma of a sweat gland Diseases 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 238000011366 aggressive therapy Methods 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 102000025171 antigen binding proteins Human genes 0.000 description 1
• 108091000831 antigen binding proteins Proteins 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 101150010487 are gene Proteins 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 238000007845 assembly PCR Methods 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 239000003833 bile salt Substances 0.000 description 1
• 229940093761 bile salts Drugs 0.000 description 1
• 238000002306 biochemical method Methods 0.000 description 1
• 229920002988 biodegradable polymer Polymers 0.000 description 1
• 239000004621 biodegradable polymer Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 210000001109 blastomere Anatomy 0.000 description 1
• 229960001561 bleomycin Drugs 0.000 description 1
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 201000008274 breast adenocarcinoma Diseases 0.000 description 1
• 201000008275 breast carcinoma Diseases 0.000 description 1
• 201000003714 breast lobular carcinoma Diseases 0.000 description 1
• DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 208000035269 cancer or benign tumor Diseases 0.000 description 1
• 229940022399 cancer vaccine Drugs 0.000 description 1
• 238000009566 cancer vaccine Methods 0.000 description 1
• 238000005251 capillar electrophoresis Methods 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 230000008244 carcinogenesis pathway Effects 0.000 description 1
• 208000002458 carcinoid tumor Diseases 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000025084 cell cycle arrest Effects 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 108091092328 cellular RNA Proteins 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 230000033077 cellular process Effects 0.000 description 1
• 230000004700 cellular uptake Effects 0.000 description 1
• 230000005591 charge neutralization Effects 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 230000035605 chemotaxis Effects 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000004252 chorionic villi Anatomy 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 238000003200 chromosome mapping Methods 0.000 description 1
• 238000007697 cis-trans-isomerization reaction Methods 0.000 description 1
• 238000013377 clone selection method Methods 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 229910017052 cobalt Inorganic materials 0.000 description 1
• 239000010941 cobalt Substances 0.000 description 1
• GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 201000011050 comedo carcinoma Diseases 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 230000030944 contact inhibition Effects 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 238000011254 conventional chemotherapy Methods 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 239000003431 cross linking reagent Substances 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 238000000326 densiometry Methods 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 108010037623 eIF-2 Kinase Proteins 0.000 description 1
• 102000010982 eIF-2 Kinase Human genes 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 108010063187 endoplasmic reticulum glycoprotein p99 Proteins 0.000 description 1
• 108010022937 endoplasmin Proteins 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 230000006353 environmental stress Effects 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 230000008202 epithelial morphogenesis Effects 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 230000032050 esterification Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 239000005038 ethylene vinyl acetate Substances 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 150000002190 fatty acyls Chemical group 0.000 description 1
• 150000002191 fatty alcohols Chemical class 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 238000001215 fluorescent labelling Methods 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• IECPWNUMDGFDKC-MZJAQBGESA-M fusidate Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-M 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 238000012226 gene silencing method Methods 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 238000012252 genetic analysis Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 108010017007 glucose-regulated proteins Proteins 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 102000006638 guanylate kinase Human genes 0.000 description 1
• 150000003278 haem Chemical class 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 210000004458 heterochromatin Anatomy 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 108090001018 hexadecanal dehydrogenase (acylating) Proteins 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 230000002434 immunopotentiative effect Effects 0.000 description 1
• 230000000091 immunopotentiator Effects 0.000 description 1
• 239000012133 immunoprecipitate Substances 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940124589 immunosuppressive drug Drugs 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 230000008676 import Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 201000004653 inflammatory breast carcinoma Diseases 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 210000004692 intercellular junction Anatomy 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 230000004068 intracellular signaling Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 206010073095 invasive ductal breast carcinoma Diseases 0.000 description 1
• 201000010985 invasive ductal carcinoma Diseases 0.000 description 1
• 206010073096 invasive lobular breast carcinoma Diseases 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 229940043355 kinase inhibitor Drugs 0.000 description 1
• 208000003849 large cell carcinoma Diseases 0.000 description 1
• 210000001069 large ribosome subunit Anatomy 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 229920006008 lipopolysaccharide Polymers 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 230000004777 loss-of-function mutation Effects 0.000 description 1
• 201000000966 lung oat cell carcinoma Diseases 0.000 description 1
• 230000009397 lymphovascular invasion Effects 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 230000008219 male gametogenesis Effects 0.000 description 1
• 208000006178 malignant mesothelioma Diseases 0.000 description 1
• 150000002690 malonic acid derivatives Chemical class 0.000 description 1
• 210000001161 mammalian embryo Anatomy 0.000 description 1
• 208000027202 mammary Paget disease Diseases 0.000 description 1
• 229910052748 manganese Inorganic materials 0.000 description 1
• 239000011572 manganese Substances 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
• 210000002752 melanocyte Anatomy 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 230000002297 mitogenic effect Effects 0.000 description 1
• 108091005601 modified peptides Proteins 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 239000006218 nasal suppository Substances 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 230000001338 necrotic effect Effects 0.000 description 1
• QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
• BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
• 101150112302 nifH gene Proteins 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 238000011580 nude mouse model Methods 0.000 description 1
• 238000002966 oligonucleotide array Methods 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 231100000590 oncogenic Toxicity 0.000 description 1
• 230000002246 oncogenic effect Effects 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 108010044156 peptidyl-prolyl cis-trans isomerase b Proteins 0.000 description 1
• 230000000858 peroxisomal effect Effects 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 235000021317 phosphate Nutrition 0.000 description 1
• 150000004713 phosphodiesters Chemical group 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 108091008695 photoreceptors Proteins 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 238000013439 planning Methods 0.000 description 1
• IJBLJLREWPLEPB-IQSNHBBHSA-N plastoquinol-9 Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=CC(O)=C(C)C(C)=C1O IJBLJLREWPLEPB-IQSNHBBHSA-N 0.000 description 1
• FKUYMLZIRPABFK-IQSNHBBHSA-N plastoquinone-9 Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=CC(=O)C(C)=C(C)C1=O FKUYMLZIRPABFK-IQSNHBBHSA-N 0.000 description 1
• 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 239000004633 polyglycolic acid Substances 0.000 description 1
• 239000004626 polylactic acid Substances 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 230000003518 presynaptic effect Effects 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 210000004908 prostatic fluid Anatomy 0.000 description 1
• 238000002731 protein assay Methods 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 108020001580 protein domains Proteins 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 239000003909 protein kinase inhibitor Substances 0.000 description 1
• PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 238000002601 radiography Methods 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 239000013074 reference sample Substances 0.000 description 1
• 230000025915 regulation of apoptotic process Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000035806 respiratory chain Effects 0.000 description 1
• 230000027756 respiratory electron transport chain Effects 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 210000001525 retina Anatomy 0.000 description 1
• 210000000880 retinal rod photoreceptor cell Anatomy 0.000 description 1
• 238000012340 reverse transcriptase PCR Methods 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 201000007416 salivary gland adenoid cystic carcinoma Diseases 0.000 description 1
• 235000020637 scallop Nutrition 0.000 description 1
• 238000003345 scintillation counting Methods 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 230000036299 sexual function Effects 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 125000005629 sialic acid group Chemical group 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 229940126586 small molecule drug Drugs 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 108091029842 small nuclear ribonucleic acid Proteins 0.000 description 1
• 238000005063 solubilization Methods 0.000 description 1
• 230000007928 solubilization Effects 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 210000004989 spleen cell Anatomy 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 239000003270 steroid hormone Substances 0.000 description 1
• 108020003113 steroid hormone receptors Proteins 0.000 description 1
• 102000005969 steroid hormone receptors Human genes 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 230000000946 synaptic effect Effects 0.000 description 1
• 210000002504 synaptic vesicle Anatomy 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 238000011200 topical administration Methods 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 231100000167 toxic agent Toxicity 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000037426 transcriptional repression Effects 0.000 description 1
• 108091006107 transcriptional repressors Proteins 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 201000007423 tubular adenocarcinoma Diseases 0.000 description 1
• 230000005751 tumor progression Effects 0.000 description 1
• 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 108091005990 tyrosine-phosphorylated proteins Proteins 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 210000000689 upper leg Anatomy 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000004482 visual phototransduction Effects 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 229950009268 zinostatin Drugs 0.000 description 1